Our top pick for
ClearOne, Inc is a communication equipment business based in the US. ClearOne shares (CLRO) are listed on the NASDAQ and all prices are listed in US Dollars. ClearOne employs 127 staff and has a trailing 12-month revenue of around USD$26.8 million.
|52-week range||USD$1.5 - USD$3.85|
|50-day moving average||USD$3.0239|
|200-day moving average||USD$2.4739|
|Wall St. target price||USD$4.05|
|Dividend yield||USD$0 (0%)|
|Earnings per share (TTM)||USD$-1.314|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing ClearOne stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ClearOne's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ClearOne's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.74. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ClearOne's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||USD$26.8 million|
|Gross profit TTM||USD$12.1 million|
|Return on assets TTM||-6.12%|
|Return on equity TTM||-15.58%|
|Market capitalisation||USD$70.4 million|
TTM: trailing 12 months
There are currently 24,470 ClearOne shares held short by investors – that's known as ClearOne's "short interest". This figure is 8.2% up from 22,612 last month.
There are a few different ways that this level of interest in shorting ClearOne shares can be evaluated.
ClearOne's "short interest ratio" (SIR) is the quantity of ClearOne shares currently shorted divided by the average quantity of ClearOne shares traded daily (recently around 128789.47368421). ClearOne's SIR currently stands at 0.19. In other words for every 100,000 ClearOne shares traded daily on the market, roughly 190 shares are currently held short.
However ClearOne's short interest can also be evaluated against the total number of ClearOne shares, or, against the total number of tradable ClearOne shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ClearOne's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ClearOne shares in existence, roughly 0 shares are currently held short) or 0.0026% of the tradable shares (for every 100,000 tradable ClearOne shares, roughly 3 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ClearOne.
Find out more about how you can short ClearOne stock.
We're not expecting ClearOne to pay a dividend over the next 12 months.
Over the last 12 months, ClearOne's shares have ranged in value from as little as $1.5 up to $3.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ClearOne's is 1.4691. This would suggest that ClearOne's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ClearOne, Inc., together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices. It also provides video products, such as video conferencing and collaboration solutions; and AV networking, which deliver the IP A/V experience by streaming time sensitive high definition audio and video, and control over TCP/IP networks. In addition, the company offers professional microphones consisting of beamforming microphones, ceiling microphones, and wireless microphones. ClearOne, Inc. sells its commercial products to a network of independent professional audiovisual, information technology, and telecommunications distributors, as well as systems integrators, dealers, value-added resellers, and end-users. The company was founded in 1983 and is headquartered in Salt Lake City, Utah.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore Technologies Inc IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.